[1]
Kantárová D, Buc M. Genetic susceptibility to type 1 diabetes mellitus in humans. Physiol Res 2007; 56: 255-66.
[2]
Skordis N, Efstathiou E, Kyriakides TC. Epidemiology of type 1 diabetes mellitus in Cyprus: rising incidence at the dawn of the 21st century. Hormones 2012; 11(1): 86-93.
[3]
International Diabetes F IDF Diabetes Atlas. 6th ed. Brussels, Belgium: International Diabetes F 2013.
[4]
Hasham A, Tomer Y. The recent rise in the frequency of type 1 diabetes: who pulled the trigger? J Autoimmune 2011; 37(1): 1-2.
[5]
Watkins RA, Evans-Molina C, Blum JS, Dimeglio LA. Established and emerging biomarkers for the prediction of type 1 diabetes: A systematic review. Transl Res 2014; 164: 110-21.
[6]
Haitao Wang, Jiangping Xu, Jiashu Chen, Peter J. Little, Wenhua Zheng. Role of IGF-1 signaling in the pathology of diabetic retinopathy. Ther Targets Neurol Dis 2015; 2e639 [doi: 10.14800/ttnd.639].
[7]
Werner H, Weinstein D, Bentov I. Similarities and differences between insulin and IGF-I: structures, receptors, and signalling pathways. Arch Physiol Biochem 2008; 114(1): 17-22.
[9]
Lohman TG, Roch AF, Martorell R, Eds. Anthropometric Standardization
Reference Manual. Human Kinetics Books,. Champaign, Illinois 1988.
[10]
Pomeroy E, Stock JT, Stanojevic S, Miranda JJ, Cole TJ, Wells JC. Trade-offs in relative limb length among peruvian children: extending the thrifty phenotype hypothesis to limb proportions. PLoS One 2012; 7(12)e51795
[11]
Gallagher D, Visser M, Sepulveda D, et al. How useful is body mass index for comparison of body fatness across age, gender, and ethnic groups? Am J Epidemiol 1996; 143: 228-39.
[12]
Luo ZC, Albertsson-Wikland K, Karlberg J. Target height as predicted by parental heights in a population-based study. Pediatr Res 1998; 44(4): 563-71.
[13]
Tapanainen P, Käär ML, Leppäluoto J, Huttunen NP, Knip M. Normal stimulated growth hormone secretion but low peripheral levels of insulin-like growth factor I in prepubertal children with insulin-dependent diabetes mellitus. Acta Paediatr 1995; 84(6): 646-50.
[14]
Acerini CL, Clayton KL, Hintz R, et al. Serum insulin-like growth factor II levels in normal adolescents and those with insulin dependent diabetes mellitus. Clin Endocrinol (Oxf) 1996; 45(1): 13-9.
[15]
Srinivas teppala and anoop shankar. association between serum
IGF-1 and diabetes among U.S. adults. Diabetes Care Octob 2010; 33(10): 2257-9.
[16]
Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB, Wareham NJ. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002; 359: 1740-5.
[17]
Rajpathak SN, McGinn AP, Strickler HD. Insulin like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults. Growth Horm IGF Res 2008; 18(2): 166-73.
[18]
Zarghami NA, Mohammad Zadeh GB, Karimi PA. Relationship between insulin like growth factor-1 and leptin in type II diabetic patients. Int J Endocrinol Metab 2009; 1: 26-34.
[19]
Bereket A, Lang CH, Wilson TA. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus. Horm Metab Res 1999; 31(2-3): 172-81.
[20]
Schaper NC. Growth hormone secretion in type 1 diabetes: a review. Acta Endocrinol 1990; 122: 7-12.
[21]
Puche JE, Castilla-Cortázar I. Human conditions of insulin-like growth factor-I (IGF-I) deficiency. J Transl Med 2012; 10: 224.
[22]
Ekman B, Nyström F, Arnqvist HJ. Circulating IGF-I concentrations are low and not correlated to glycaemic control in adults with type 1 diabetes. Eur J Endocrinol 2000; 143(4): 505-10.
[23]
Estakhri M, Jalali M, Djazayery A, et al. Insulin-like growth factor-1 levels in children and adolescents with type1 diabetes mellitus and its relationship with serum zinc. Iranian J Diabetes Lipid Disorders 2011; 10: 1-6.
[24]
Cianfarani S, Bonfanti R, Bitti ML, et al. Growth and Insulin-Like Growth Factors (IGFs) in children with insulin-dependent diabetes mellitus at the onset of disease: evidence for normal growth, age dependency of the IGF system alterations, and presence of a small (Approximately 18-Kilodalton) IGF-binding protein-3 fragment in serum. J Clin Endocrinol Metab 2000; 85(11): 4162-7.
[25]
Lebl J, Schober E, Zidek T, et al. Growth data in large series of 587 children and adolescents with type 1 diabetes. Endocr Regul 2003; 37(3): 153-61.
[26]
Chiarelli F, Giannini C, Mohn A. Growth, growth factors and diabetes. Eur J Endocrinol 2004; 151: U109-17.
[27]
Onah CE, Meludu SC, Dioka CE, et al. Pattern of male sex hormones in type 2 diabetic patients in Nnewi, South Eastern Nigeria. IOSR J Dental Med Sci 2013; 10(4): 65-70.
[28]
Adegbesan BO, Ogunlabi OO. The effect of type 1 diabetes on reproductive hormones (follicle stimulating, luteinizing and testosterone hormones) in human male subjects. FASEB J 2013; 27: lb740.
[29]
Ballester J, Muñoz MC, Domínguez J, et al. Insulin-dependent diabetes affects testicular function by FSH- and LH-Linked mechanisms. J Androl 2004; 25(5): 706-19.
[30]
Palta M, LeCaire TJ, Sadek-Badawi M, Herrera VM, Danielson KK. The trajectory of IGF-1 across age and duration of type 1 diabetes. Diabetes Metab Res Rev 2014; 30(8): 777-83.